Top Institutions in Ophthalmology - Retinal Diseases
Leading academic ophthalmology centers utilize large clinical registries like the IRIS Registry and conduct prospective and retrospective studies to evaluate anti-VEGF therapies such as aflibercept in retinal diseases, emphasizing real-world effectiveness and treatment optimization.
-
#1
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital is a world-renowned leader in retinal disease research and clinical trials, with extensive expertise in AMD and DME treatments and significant contributions to anti-VEGF therapy development and real-world outcome studies.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#2
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a robust retina division, leading numerous clinical trials on anti-VEGF agents and real-world treatment strategies for AMD and DME.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#3
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a leader in translational retinal research with a focus on innovative therapies for AMD and DME, contributing extensively to registry-based studies and real-world evidence generation.
Key Differentiators
- Ophthalmology
- Retina
- Translational Research
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a distinguished retina research program with expertise in clinical trials and registry analyses for retinal vascular diseases including AMD and DME.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







